InvOpps IV US, L.P., Director, 10% Owner at Oyster Point Pharma, Inc. (OYST), bought 178,571 shares at $28.00 ($5.0M) on 2020-05-19, disclosed to the SEC on 2020-05-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 59,178 | $1.7M | 33.1% |
| 2 | $28.00 | 119,393 | $3.3M | 66.9% |
| Total | $28.00 avg | 178,571 | $5.0M | 100% |